Effect of Colchicine vs Usual Care Alone on Intubation and 28-Day Mortality in Patients Hospitalized With COVID-19

Authors:

Abstract
Respiratory complications leading to intubation or death occur in 25% of patients admitted to the hospital with COVID-19.1 Dexamethasone2 and tocilizumab3 have reduced mortality in hospitalized patients with severe COVID-19 pneumonia, whereas hydroxychloroquine, chloroquine, interferon, remdesivir, azithromycin, and convalescent plasma4-7 failed to do so.